956-16118-82463
5 vaccinations
8 coded responses
43 check-ins
7 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 024 / MA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Survey response — day 21, dose 1MedDRA: COVID-19, Cough, Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to workFree text: I have Covid. Became positive on 1/11. Symptoms include low grade fevers, fatigue, dry cough, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-20
- 2021-01-27
- 2021-02-03
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-21
- 2021-02-26
- 2021-03-05
- 2021-03-13
- 2021-03-19
-
2021-05-07
Survey response — 3 months, dose 2MedDRA: Fatigue, Post-acute COVID-19 syndrome, Pre-existing disease — Feeling: FairFree text: I believe I have long Covid. ExhaustedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-06
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Oedema peripheral — Feeling: Fair · Site: Pain, SwellingFree text: Ipsilateral under the arm swelling. Presumably adenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Ipsilateral Axillary adenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: SwellingFree text: Axillary adenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activitiesFree text: New Covid diagnosisMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: COVID-19, Fatigue — Feeling: FairFree text: I cannot remember last contact by I had Covid again on 12/30/21. I believe has affected health after first illness. Severe fatigue with exercise that has never quite resolved.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Dose 4 — Pfizer-BioNTech
- 2022-10-01
-
2022-10-19
Dose 5 — Pfizer-BioNTech
- 2022-10-20
- 2022-10-22
- 2022-10-23
- 2022-10-25
- 2022-10-28
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
-
2023-01-18
Survey response — 3 months, dose 5MedDRA: Fatigue, Influenza — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-05-27 | Pfizer-BioNTech | No |
| 5 | 2022-10-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 21, dose 1
Symptoms: I have Covid. Became positive on 1/11. Symptoms include low grade fevers, fatigue, dry cough, congestion
Release 8 — 3 months, dose 2
Symptoms: I believe I have long Covid. Exhausted
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Ipsilateral under the arm swelling. Presumably adenopathy
Systemic reaction (other): Ipsilateral Axillary adenopathy
Systemic reaction (other): Axillary adenopathy
Release 10 — 3 months, dose 3
Symptoms: New Covid diagnosis
Release 11 — 6 months, dose 3
Symptoms: I cannot remember last contact by I had Covid again on 12/30/21. I believe has affected health after first illness. Severe fatigue with exercise that has never quite resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | ✓ | ✓ | ○ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release